Hannah Monyer, Heidelberg
W.E. Whitehead, Chapel Hill, USA

State of the Art Symposien

  • Traumatherapie
  • Psychosomatik im Kindes- und Jugendalter – Ein fester Bestandteil des Fachgebietes
  • Psychosoziale und psychosomatische Aspekte der Adipositas-Chirurgie
  • Cutting edge-Forschung in der Psychosomatik
  • Therapeutische Beziehungsgestaltung
  • Neue Entwicklungen in der Therapie von Essstörungen
  • Neuromodulatorische Ansätze zur Therapie von Essstörungen und Übergewicht
  • Zwanghaftes Verhalten und Zwangsgedanken
  • Therapie der hochgradigen Anorexia nervosa
  • Schmerzstörungen
  • Impulsive Verhaltensweisen
  • Psychosomatische Rehabilitation
  • Somatoforme Störungen
  • Prävention und Frühintervention bei psychischen Störungen
  • Evidenzbasierte Systemische Therapie: Forschung und Praxis
  • Trauma und Herz-Kreislauferkrankungen: Evidenz, pathogenetische Mechanismen und therapeutische Konsequenzen
  • Gender und sexuelle Orientierung in der Psychotherapie


Bair color crop

Matthew J. Bair

  • Research Scientist, Regenstrief Institute, Inc. and Indiana University Center for Health Services and Outcomes Research
  • Associate Professor of Medicine, Indiana University School of Medicine
  • Core Investigator, VA Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center

Dr. Bair’s research focuses on understanding the interface between affective disorders (e.g. depression and anxiety) and chronic pain, and developing strategies to improve pain management in the primary care setting. Dr. Bair’s major educational foci are teaching implementation research methods and evidence-based medicine to medical residents, fellows, and junior faculty.

Zurück zum Seitenanfang


Lone Overby Fjorback

Lone Overby Fjorback, PhD, MD, psychiatrists, is an associate professor of medicine, director of the Danish Center for Mindfulness, Institute of Clinical Medicine, Aarhus University, Denmark. As a mindfulness teacher, researcher and psychiatrist, she has worked with patients suffering from stress, pain, fatigue, anxiety, PTST and depression. In collaboration with Center For Mindfulness, University of Massachusetts Medical School she is engaged in professional education and training program leading to teacher certification in mindfulness-based stress reduction (MBSR). Lone is the author of the PhD thesis ‚Mindfulness and Bodily Distress‘ including a mindfulness workbook and papers demonstrating that even patients with chronic stress disorders and low social economic status and resources can benefit from the MBSR programme and reduce healthcare costs
Her work and the MBSR programme can be seen in a documentary ‚Mindful Medicine‘
Lone contributed with the following bookchapters: ‚Individuals in Chronic Pain‘. In: Donald McCown, Diane K. Reibel, Marc S. Micozzi (eds.), Resources for Teaching Mindfulness: A Cross-Cultural and International Handbook, Springer 2016.

‚Mindfulness for the treatment of stress disorders‘ and ‚What is Required to Teach Mindfulness Effectively in MBSR and MBCT‘. In E. Y. Shonin, W. Van Gordon and M. D. Griffiths (eds.), Mindfulness and other Buddhist-Derived Approaches in Mental Health and Addiction, Advances in Mental Health and Addiction Series. Springer, 2016.

Van Ravesteijn Hiske & Lone Overby Fjorback. Mindfulness-based cognitive therapy: medically unexplained symptoms. In: Stuart Eisendrath, Mindfulness-Based Cognitive Therapy:  Innovative Applications. Springer, 2016.

Zurück zum Seitenanfang

Per Fink_beskåret

Per Fink

Prof. Per Fink heads The Research Clinic for Functional Disorders, Aarhus University Hospital; an interdisciplinary clinic focusing primarily on research in functional symptoms or medically unexplained symptoms as well as on developing treatment programmes for patients with these symptoms. The clinic treats patients with functional disorders, which includes functional somatic syndromes and health anxiety.
Per Fink has an extensive publication list and teaching experience and is among the leading researchers within this area.

Zurück zum Seitenanfang


Ap Dijksterhuis

Ap Dijksterhuis is Professor of Psychology at the Radboud University Nijmegen. He published widely about unconscious processes and won many scientific awards such as the APA Award for Early Career Contributions, the SESP Career Trajectory Award, and the Kurt Lewin Award of EASP. Dijksterhuis is member of the board of reviewing editors of Science. In 2007, he published the trade book Het slimme onbewuste (“The smart unconscious”) that became a bestseller in the Netherlands. That same year, the influential magazine HP/De Tijd chose him among the 100 most influential people of the Netherlands.

Zurück zum Seitenanfang

Ap Dijksterhuis ist Psychologieprofessor an der Radboud Universität Nijmegen. Er veröffentlichte weitgehend über unbewusste Prozesse und gewann viele wissenschaftliche Preise wie den APA-Preis für frühe Karrierebeiträge, den SESP Karriereflugbahnpreis und den Kurt Lewin Preis der EASP. Dijksterhuis ist Mitglied des Aufsichtsrats bei den Nachprüfern für Redakteure im Bereich Naturwissenschaften. Im Jahr 2007 veröffentlichte er das Handelsbuch „Het slimme onbewuste“ (Das kluge Unbewusste), welches ein Bestseller in den Niederlanden wurde. Im selben Jahr, wählte ihn das einflussreiche Magazin HP/De Tijd unter die Top 100 der einflussreichsten Menschen der Niederlanden.

M Härter November 2015 (3)

Martin Härter

Martin Härter, Dipl Psych MD PhD Professor of Medical Psychology. M. Härter has been trained in psychology and medicine at the universities of Würzburg, Padova (Italy) and Freiburg. He received his MD (1991) and his PhD (1993) in Psychology at the University of Freiburg and is a licensed psychotherapist. He was Director of the Section of Clinical Epidemiology and Health Services Research at the Department of Psychiaty and Psychotherapy in Freiburg. Since 2008 he is Director of the Department of Medical Psychology at the University Medical Center Eppendorf (UKE) in Hamburg.
He coordinated the German National Clinical Practice Guideline for Depression from 2005-2016 and is since 2008 member of the expert panel of the German National Cancer Plan. Since 2010 he is spokesman of the Center for Health Care Research (chcr) at the UKE and since 2011 spokesman of “psychenet – the Hamburg Network for Mental Health”. Since 2016 he is Chairman of the Scientific Advisory Board of the Agency for Quality in Medicine (Berlin).
His main research interests are in somato-psychological comorbidity, epidemiology of mental disorders in chronic diseases, depression care, patient-centred care and shared decision-making as well as in health services research in general.


Zurück zum Seitenanfang


Stefan Hofman

Stefan G. Hofmann, Ph.D. is Professor of Psychology at Boston University, where he is the Director of the Psychotherapy and Emotion Research Laboratory. He was former president of ABCT and is current president of the IACP. He is also the editor-in-chief of Cognitive Therapy and Research and the Associate Editor of Clinical Psychological Science. He has published more than 300 peer-reviewed journal articles and 15 books. He has been selected as a Highly Cited Researcher by Thomson Reuters in 2015. His research focuses on the mechanism of treatment change, translating discoveries from neuroscience into clinical applications, emotion regulation, and cultural expressions of psychopathology.

Zurück zum Seitenanfang

Prof. R Horne photo

Robert Horne

Rob Horne is Professor of Behavioural Medicine at University College London (UCL) School of Pharmacy, where he is Director of the Centre for Behavioural Medicine and UCL Academic Lead for the Centre for the Advancement of Sustainable Medical Innovation (CASMI), a joint undertaking with the University of Oxford.
His research focusing on the role of psychological and behavioural factors in explaining variation in response to treatment. His current interests centre on the development of interventions to support optimal engagement with essential treatments and effective medical innovations and on optimising the non-specific effects (placebo and nocebo components) of medicines.
In the last decade, his research has generated over 140 peer-reviewed publications and grants of over £30 million (£4.9 million as Principal Investigator).
He is a Founding Fellow of the Royal Pharmaceutical Society of Great Britain in 2010, Fellow of the Faculty of Pharmaceutical medicine, Royal College of Physicians.

Zurück zum Seitenanfang


Willem J. Kop

Willem J. Kop is Full Professor of Medical and Clinical Psychology at Tilburg University, the Netherlands. His primary expertise is in the interaction of psychological and biological processes as risk factors for cardiovascular disease. Professor Kop received his Ph.D. in Medical Psychology from Maastricht University, the Netherlands in 1994. He then relocated to the United States to take a post-doctoral fellowship at the Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD (Chair Jerome E. Singer), where he continued his research and teaching activities until 2006.  He left USUHS to initiate the behavioral cardiology research program in the Division of Cardiology at the University of Maryland, Baltimore, MD. He is the current Editor-in-Chief of Psychosomatic Medicine. He was appointed Full Professor at Tilburg University in 2010 and currently investigates biobheavioral processes of health and disease with a focus on acute and chronic psychological risk factors for cardiovascular disease.

Zurück zum Seitenanfang


Patrick Luyten

Patrick Luyten, PhD is Associate Professor at the Faculty of Psychology and Educational Sciences, University of Leuven (Belgium) and Reader at the Research Department of Clinical, Educational, and Health Psychology, University College London (UK). He is also an Assistant Professor, Adjunct at the Yale Child Study Center in New Haven, CT, USA.
His main research interests are disorders from the affective spectrum (i.e., depression and stress- and pain-related disorders), and personality disorders. In both areas he is involved in basic research and in interventional research. His basic research focuses on the roles of personality, attachment and social cognition or mentalizing, i.e., the capacity to understand oneself and others in terms of mental states, in these disorders from a developmental psychopathology perspective.
Dr. Luyten’s research is fundamentally translational, as he is interested in translating knowledge concerning the mechanisms involved in the causation of psychopathology to the development of new interventions, the evaluation of their (cost)-effectiveness, and their dissemination to and implementation in routine clinical care. In recent years, his research has increasingly focused on the development of interventions based on an integrative, evolutionary perspective rooted in the capacity for epistemic trust and salutogenesis, i.e., the capacity to derive benefit from the social environment.
Dr. Luyten is Director of the PhD in Psychoanalysis Programme, and Course Director of the PhD programme in Evidence Based Child and Adolescent Mental Health, both at University College London, UK. He serves on the editorial board of several scientific journals. He heads a treatment service for patients with depression and functional somatic disorders in PraxisP, the treatment center of the Faculty of Psychology and Educational Sciences from the KU Leuven, Belgium.

Zurück zum Seitenanfang

Prof. Dr. Giovanni Maio

Giovanni Maio

Giovanni Maio ist Internist und Philosoph; er habilitierte sich im Jahre 2000 für das Fach Ethik in der Medizin. 2004 erhielt er mehrere Rufe auf medizinethische Lehrstühle im In- und Ausland und nahm den Ruf auf den Lehrstuhl für Medizinethik an der Albert-Ludwigs-Universität Freiburg an, wo er zum Direktor des Instituts für Ethik und Geschichte der Medizin bestellt wurde. 2002 wurde er von der Bundesregierung in die Zentrale Ethikkommission für Stammzellforschung berufen, 2007 in den Ausschuss für ethisch-juristische Grundsatzfragen, 2010 zum ständigen Berater der Deutschen Bischofskonferenz ernannt. Über 400 Artikel zur Medizinethik und zahlreiche Bücher, neueste Buchpublikationen „Mittelpunkt Mensch – Lehrbuch zur Ethik in der Medizin“ (2017), „Den kranken Menschen verstehen – Für eine Medizin der Zuwendung.“ (2016), „Geschäftsmodell Gesundheit – Wie der Markt die Heilkunst abschafft“ (2014).

Zurück zum Seitenanfang

D. McMillan

Dean McMillan

Dean McMillan is a clinical psychologist and Senior Lecturer in Mental Health Services Research at Hull York Medical School and the Department of Health Sciences, University of York, UK. His main research interests are the development and evaluation of low-intensity psychological interventions, behavioural treatments, and the evaluation of screening and case-finding instruments for common mental health problems.

Zurück zum Seitenanfang

Dr. Anja Mehnert

Anja Mehnert

Anja Mehnert, Ph.D., is Professor of Medical Psychology at the University Medical Center Leipzig, where she is chair of the Department of Medical Psychology and Medical Sociology. She is co-editor of Psychotherapie Psychosomatik Medizinische Psychologie and serves on the editorial board of several journals including Psycho-Oncology and the Journal of Cancer Survivorship. Her research focuses on psycho-oncology, cancer survivorship, health care services research and interventions for patients with advanced illness. In 2016, she was awarded the German Cancer Award and she is president of the 2017 World Congress for Psycho-Oncology in Berlin.

Zurück zum Seitenanfang


Hannah Monyer

Prof. Dr. Hannah Monyer (* 03.10.1957)
Abteilung Klinische Neurobiologie
der Medizinischen Fakultät der Universität Heidelberg
und des Deutschen Krebsforschungszentrums (DKFZ)

Seit 09/2009 Direktorin der Kooperationseinheit “Klinische Neurobiologie” am DKFZ
Seit 05/1999 C4 Professur, Medizinische Fakultät der Universität Heidelberg
10/94-04/99 C3 Professur der Schilling-Stiftung am ZMBH Heidelberg
10/89-94 Postdoc am ZMBH
07/86-09/89 Postdoc am Stanford University Medical Center, USA
07/84-06/86 Assistenzärztin, Abt. Pädiatrische Neurologie, Univ. Lübeck
01/83-06/84 Assistenzärztin, Abt. Kinder- und Jugendpsychiatrie, ZI Mannheim
09/76-07/82 Medizinstudium an der Universität Heidelberg, Doktorarbeit mit dem
Thema „Das Phänomen ‚Eifersucht‘ bei Marcel Proust und in der
Psychiatrie seiner Zeit“ – betreut von Prof. Dr. Dietrich von Engelhardt,
Institut für Geschichte der Medizin, Universität Heidelberg
09/72-06/75 Special English Highschool in Cluj/Rumänien
09/64-06/72 Grund- und Musikschule in Hunedoara/Rumänien

2016 Tsungming Tu Award (TTA), Ministry of Science and Technology,
Taipei, Taiwan, ROC
2016 Mitglied der Academia Europaea (The Academy of Europe)
2009 ERC Advanced Grant, proposal no. 250047 „GABAcellsAndMemory“
2005 Prix Franco-Allemand Gay-Lussac – Humboldt
2004 Gottfried Wilhelm Leibniz Preis der DFG
1999 Bundesverdienstkreuz am Bande
1977-1982 Stipendium der Studienstiftung des Deutschen Volkes

• Synaptische Plastizität
• Postnatale Neurogenese
• Zelluläre und netzwerkbedingte Grundlagen von Lernen und Gedächtnis

Zurück zum Seitenanfang

Foto - M.R.

Matthias Rose

Prof. Dr. med. Matthias Rose ist Direktor der Medizinischen Klinik mit Schwerpunkt Psychosomatik am Centrum für Innere Medizin und Dermatologie der Charité in Berlin und Associate Professor für Outcome Measurement am Department for Quantitative Health Sciences der Medical School der University of Massachusetts. Seit zehn Jahren unterrichtet er zudem über moderne psychometrische Methoden an der Harvard University in Boston.

Er ist Facharzt für Innere Medizin und Facharzt für Psychosomatik und psychodynamisch arbeitender Psychotherapeut. Seine internistische Ausbildung erfolgte zunächst auf der Intensivstation am damaligen Klinikum Westend bevor er seine Ausbildung an verschiedenen Medizinischen Kliniken am Virchow Klinikum fortsetzte. Dort erhielt er später auch seine erste Stelle als Oberarzt in der Medizinischen Klinik mit Schwerpunkt Psychosomatik. Ende 2007 nahm er die Position des geschäftsführenden Oberarztes am Institut für Psychosomatische Medizin und Psychotherapie am Universitätsklinikum Eppendorf und der Psychosomatischen Klinik der Schön-Klinik in Hamburg Eilbek an, wo er seine Ausbildung zum Facharzt für Psychosomatik und Psychotherapie beendete und bis zur Übernahme der Position des Klinikdirektors an der Charité 2012 arbeitete.

Wissenschaftlich beschäftigt sich Prof. Dr. Rose seit über 20 Jahren mit der Erfassung der Lebensqualität bei chronischen Erkrankungen. und der Entwicklung moderner psychometrischer Methoden. Seit ca. 15 Jahren ist er Teil der Arbeitsgruppe um Prof. Dr. J. Ware, dem Entwickler des SF-36, mit dem er von 2004-2007 in Boston zusammenarbeitete. Seither ist er Mitentwickler des Patient-Reported Outcome Measurement Information Systems (PROMIS), einer von allen U.S. amerikanischen National-Institutes of Health geförderten Initiative zur Standardisierung der Erfassung patienten-berichteter Merkmale. Er leitet die Arbeitsgruppe des International Consortium for Health Outcome Measurement (ICHOM) zur Messung von Depressivität und Angst und seine Abteilung unterstützt die Entwicklung verbesserter Messinstrumente der European Organization for Research and Treatment of Cancer (EORTC). Prof. Dr. Rose erhielt für seine Arbeiten im Bereich der Erfassung der Lebensqualität mehrere Forschungspreise, u.a. den Lilly Quality of Life Award und den Heinrich Bauer Preis. Seine Arbeiten wurden von Deutschen Forschungsgemeinschaft (DFG), dem Bundesministerium für Bildung und Forschung (BMBF) und verschiedenen National Institutes of Health (NIH) in den USA gefördert.

Zurück zum Seitenanfang


William Whitehead

Dr. William Whitehead is a Professor of Medicine at the University of North Carolina at Chapel Hill and Director of the Center for Functional GI and Motility Disorders within the Department of Gastroenterology and Hepatology. His career has focused heavily on Irritable Bowel Syndrome (IBS) and Fecal Incontinence (FI) research. As a career investigator, he has been continuously funded by the National Institutes of Health (NIH) since 1977 and has received over 35 NIH grants. He is a board member for the Rome Foundation and his research was pivotal in the development of the Rome IV diagnostic questionnaires.

Zurück zum Seitenanfang

S. Zipfel

Stephan Zipfel

Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospi-tal Tübingen, Germany
Stephan Zipfel, has passed his MD and PhD at the University of Heidelberg, Germany and was trained in Internal Medicine as well as Psychosomatic Medicine and Psychotherapy at the University Medical Hospital Heidelberg. Since 2003 he is full professor (chair and head) of the Department of Psychosomatic Medicine at the University Medical Hospital Tuebingen and since 2006 Dean of Medical Education at the University of Tuebingen. He is director of the Centre of Excellence for Eating Disorders (KOMET) and was principle investigator of the larg-est treatment trial in anorexia nervosa (ANTOP). He also serves as chair of Psychooncology at the Comprehensive Cancer Centre Tübingen-Stuttgart. Since 2012 he is president of the German College of Psychosomatic Medicine (DKPM). He serves as editor and member of editorial boards (e.g. PPmP, BMC-Journal of Eating Disorders, The Lancet Psychiatry, Psy-chotherapy and Psychosomatics).
His research interests are: psychotherapy in eating disorders, psychobiology in eating disor-ders and obesity; mechanisms on placebo effect; medical education and Psychooncology.

Zurück zum Seitenanfang